Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest

Journal of Infection and Chemotherapy

Volumn 7, Issue 4, 2001, Pages 263-266

  Terakubo, S ^a   Takemura, H ^a   Yamamoto, H ^a   Ikejima, H ^a   Kunishima, H ^a   Kanemitsu, K ^a   Kaku, M ^b   Shimada, J ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Etest; Everninomicin; Gram positive cocci; MIC

Indexed keywords

EVERNIMICIN; EVERNINOMICIN; MINOCYCLINE; OLIGOSACCHARIDE; TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DEVICE; DILUTION; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0035703038     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560170025     Document Type: Article

References (12)

1. Everninomicin, a new antibiotic complex from Micromonospora carbonacea
2. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH 27899): Implications for mechanism of action
3. Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin)
4. In vitro evaluation of antimicrobial activities of SCH 27899 (everninomicin) against gram positive cocci using Etest
5. Everninomicin, a new oligosaccharide antibiotic: Its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity
6. In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis
7. In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis
8. In vivo activity and pharmacokinetics of ziracin (SCH 27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia
9. Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria
10. Antimicrobial activity and spectrum of SCH 27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control
11. Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: Disk diffusion/etest method evaluations and quality control guidelines